The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies
Open accessAbstract
Enterohemorrhagic Escherichia coli (EHEC) are responsible for major outbreaks of bloody diarrhea and hemolytic uremic syndrome (HUS) throughout the world. The mortality associated with EHEC infections stems from the production and release of a potent Shiga toxin (Stx) by these bacteria. Stx induces cell death in endothelial cells, primarily in the urinary tract, causing HUS. Stx was first described in Shigella dysenteriae serotype I by Kiyoshi Shiga and was discovered later in EHEC. Multiple environmental cues regulate the expression of Stx, including temperature, growth phase, antibiotics, reactive oxygen species (ROS), and quorum sensing. Currently, there is no effective treatment or prophylaxis for HUS. Because antibiotics trigger Stx production and their use to treat EHEC infections is controversial, alternative therapeutic strategies have become the focus of intense research. One such strategy explores quorum sensing inhibitors as therapeutics. These inhibitors target quorum sensing regulation of Stx expression without interfering with bacterial growth, leading to the hypothesis that these inhibitors impose less selective pressure for bacteria to develop drug resistance. In this review, we discuss factors that regulate Stx production in EHEC, as well as novel strategies to prevent and/or minimize the development of HUS in infected subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular Control of the Synthesis and Activity of the Bacterial Luminescent System
Nealson, K. H., Platt, T., & Hastings, J. W. (1970) · Journal of Bacteriology · doi:10.1128/jb.104.1.313-322.1970 · Cited by 1,301
Epidemiology of Escherichia coli O157:H7 Outbreaks, United States, 1982–2002
Rangel, J. M., Sparling, P. H., Crowe, C., Griffin, P. M., & Swerdlow, D. L. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1104.040739 · Cited by 1,263
Bacteria–host communication: the language of hormones
Sperandio, V., Torres, A. G., Jarvis, B., Nataro, J. P., & Kaper, J. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1537100100 · Cited by 902 · cited 2×
“AIs are hormone-like compounds produced by commensal and pathogenic bacteria, and they are involved in the coordination of behavior and adaptive responses (Sperandio et al., 2003).”
BackgroundSelf-citationAnalysis of foodborne outbreak data reported internationally for source attribution
Greig, J. D., & Ravel, A. (2009) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.12.031 · Cited by 451 · cited 2×
“REVIEW ARTICLE published: 07 June 2012 doi: 10.3389/fcimb.2012.00081 Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies”
BackgroundInfluentialThe QseC Adrenergic Signaling Cascade in Enterohemorrhagic E. coli (EHEC)
Hughes, D. T., Clarke, M. B., Yamamoto, K., Rasko, D. A., & Sperandio, V. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000553 · Cited by 244
Self-citationQseC Mediates Salmonella enterica Serovar Typhimurium Virulence In Vitro and In Vivo
Moreira, C. G., Weinshenker, D., & Sperandio, V. (2010) · Infection and Immunity · doi:10.1128/iai.01038-09 · Cited by 195 · cited 2×
“, 2006), Salmonella typhimurium (Bearson and Bearson, 2008; Moreira et al., 2010) and Francisella tularensis (Weiss et al.”
BackgroundSelf-citationReading, N. C., Torres, A. G., Kendall, M. M., Hughes, D. T., Yamamoto, K., & Sperandio, V. (2007) · Journal of Bacteriology · doi:10.1128/jb.01848-06 · Cited by 140
Self-citation
Cited by
(BIOHAZ), E. P. O. B. H., Koutsoumanis, K., Allende, A., Alvarez‐Ordóñez, A., Bolton, D., Bover‐Cid, S., Chemaly, M., Davies, R., De Cesare, A., Hilbert, F., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6377 · Cited by 445
Bacterial defences: mechanisms, evolution and antimicrobial resistance
Smith, W. P. J., Wucher, B. R., Nadell, C. D., & Foster, K. R. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00877-3 · Cited by 385
Current pathogenic Escherichia coli foodborne outbreak cases and therapy development
Yang, S.-C., Lin, C.-H., Aljuffali, I. A., & Fang, J.-Y. (2017) · Archives of Microbiology · doi:10.1007/s00203-017-1393-y · Cited by 366
Interactions between probiotics and pathogenic microorganisms in hosts and foods: A review
Mousavi Khaneghah, A., Abhari, K., Eş, I., Soares, M. B., Oliveira, R. B. A., Hosseini, H., Rezaei, M., Balthazar, C. F., Silva, R., Cruz, A. G., et al. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.11.022 · Cited by 275
In, J., Foulke-Abel, J., Zachos, N. C., Hansen, A.-M., Kaper, J. B., Bernstein, H. D., Halushka, M., Blutt, S., Estes, M. K., Donowitz, M., et al. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.10.001 · Cited by 239
Isothiocyanates: An Overview of Their Antimicrobial Activity against Human Infections
Romeo, L., Iori, R., Rollin, P., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23030624 · Cited by 230
The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
Bury, S., Soundararajan, M., Bharti, R., von Bünau, R., Förstner, K. U., & Oelschlaeger, T. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00929 · Cited by 21
Metadata
- Authors
- Pacheco, A. R., & Sperandio, V.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 2
- Pages
- 81-81
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W2127099767
- Cited by
- 165
- References
- 7
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.